相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Leptin but not neuropeptide Y up-regulated glucagon-like peptide 1 receptor expression in GTI-7 cells and rat hypothalamic slices
Carmen Sanz et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2008)
Glycemia, lipidemia and systolic left ventricular function evaluated by myocardial strain rate: A tissue doppler echocardiographic study
Niels Holmark Andersen et al.
ULTRASOUND IN MEDICINE AND BIOLOGY (2008)
Adiponectin level and left ventricular hypertrophy in Japanese men
Hirotsugu Mitsuhashi et al.
HYPERTENSION (2007)
Downregulation of GLP-1 and GIP receptor expression by hyperglycemia - Possible contribution to impaired incretin effects in diabetes
Gang Xu et al.
DIABETES (2007)
Glucagon-like peptide-1 infusion improves left ventricular ejection fraction and functional status in patients with chronic heart failure
George G. Sokos et al.
JOURNAL OF CARDIAC FAILURE (2006)
P38 MAP kinase activity is correlated with angiotensin II type 1 receptor blocker-induced left ventricular reverse remodeling in spontaneously hypertensive heart failure rats
Qiangrong Liang et al.
JOURNAL OF CARDIAC FAILURE (2006)
Direct effects of glucagon-like peptide-1 on myocardial contractility and glucose uptake in normal and postischemic isolated rat hearts
Tingcun Zhao et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Xanthine oxidoreductase inhibition causes reverse remodeling in rats with dilated cardiomyopathy
KM Minhas et al.
CIRCULATION RESEARCH (2006)
Low-intensity exercise training delays onset of decompensated heart failure in spontaneously hypertensive heart failure rats
CA Emter et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2005)
The long-acting glucagon-like peptide-1 analogue, liraglutide, inhibits β-cell apoptosis in vitro
S Bregenbolt et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Glucagon-like peptide 1 can directly protect the heart against ischemia/reperfusion injury
AK Bose et al.
DIABETES (2005)
Glucagon-like peptide-1 limits myocardial stunning following brief coronary occlusion and reperfusion in conscious canines
LA Nikolaidis et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Effects of glucagon-like peptide-1 in patients with acute myocardial infarction and left ventricular dysfunction after successful reperfusion
LA Nikolaidis et al.
CIRCULATION (2004)
The development of myocardial insulin resistance in conscious dogs with advanced dilated cardiomyopathy
LA Nikolaidis et al.
CARDIOVASCULAR RESEARCH (2004)
Recombinant glucagon-like peptide-1 increases myocardial glucose uptake and improves left ventricular performance in conscious dogs with pacing-induced dilated cardiomyopathy
LA Nikolaidis et al.
CIRCULATION (2004)
Adiponectin-mediated modulation of hypertrophic signals in the heart
R Shibata et al.
NATURE MEDICINE (2004)
Associations among plasma adiponectin, hypertension, left ventricular diastolic function and left ventricular mass index
SJ Hong et al.
BLOOD PRESSURE (2004)
Glucagon-like peptide-1 prevents beta cell glucolipotoxicity
J Buteau et al.
DIABETOLOGIA (2004)
Glucagon-like peptide 1 inhibits cell apoptosis and improves glucose responsiveness of freshly isolated human islets
L Farilla et al.
ENDOCRINOLOGY (2003)
Glucagon-like peptide-1 receptor is involved in learning and neuroprotection
MJ During et al.
NATURE MEDICINE (2003)
Combined effects of low-dose oral spironolactone and captopril therapy in a rat model of spontaneous hypertension and heart failure
A Kambara et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2003)
Cardiac function in mice lacking the glucagon-like peptide-1 receptor
R Gros et al.
ENDOCRINOLOGY (2003)
Glucagon-like peptide-1 inhibits apoptosis of insulin-secreting cells via a cyclic 5′-adenosine monophosphate-dependent protein kinase A- and a phosphatidylinositol 3-kinase-dependent pathway
HX Hui et al.
ENDOCRINOLOGY (2003)
Glucagon-like peptide-1 receptor signaling modulates β cell apoptosis
YZ Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Glucagon-like peptide 1 induces pancreatic beta-cell proliferation via transactivation of the epidermal growth factor receptor
J Buteau et al.
DIABETES (2003)
Glucagon-like peptide-1 promotes islet cell growth and inhibits apoptosis in Zucker diabetic rats
L Farilla et al.
ENDOCRINOLOGY (2002)
Exendin 4 up-regulates expression of PDX1 and hastens differentiation and maturation of human fetal pancreatic cells
J Movassat et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2002)
Glucagon-like peptide-1 treatment delays the onset of diabetes in 8 week-old db/db mice
Q Wang et al.
DIABETOLOGIA (2002)
Protection and reversal of excitotoxic neuronal damage by glucagon-like peptide-1 and exendin-4
T Perry et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Glycogen synthase kinase-3β -: A novel regulator of cardiac hypertrophy and development
SE Hardt et al.
CIRCULATION RESEARCH (2002)
Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and β-cell function in type 2 diabetes:: a parallel-group study
M Zander et al.
LANCET (2002)
Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo
SC Bodine et al.
NATURE CELL BIOLOGY (2001)
Protein kinase Cζ activation mediates glucagon-like peptide-1-induced pancreatic β-cell proliferation
J Buteau et al.
DIABETES (2001)
MMP/TIMP expression in spontaneously hypertensive heart failure rats: the effect of ACE- and MMP-inhibition
H Li et al.
CARDIOVASCULAR RESEARCH (2000)
分享论文
